Chanelle McCoy Health Claims First Positive EFSA Opinion on CBD Novel Food Application
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
24 results for “comment”
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
Two years on from the legalisation of medical cannabis in Ukraine, patients have received the first legal prescriptions for cannabis-based medicines.
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
The former heavyweight boxing contender revealed he is using prescribed medical cannabis to manage chronic pain.
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
A comprehensive guide on how to read and interpret cannabis research.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
What was once hailed as a historic victory has become a ‘national failure’, campaigners say.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
The first official evaluation of the CanG reforms highlights early trends in market growth, youth use, health outcomes, and crime.
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
Jordan Stephens aims to shed light on the role of alternative treatments in supporting mental wellbeing.
Cannabis Health has partnered with experts at the Medical Cannabis Clinicians Society to host its first event for healthcare professionals.
New analysis has found that NHS access to medical cannabis could help thousands of patients with chronic conditions return to work.